MASAYUKI NIGO M.D.
Prescription History 1801109921
Internal Medicine - Infectious Disease in Houston, TX
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MASAYUKI NIGO M.D., an active Infectious Disease specialist practicing in Houston, TX. Our medical registry currently tracks 8 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 169 documented patient claims. Among these therapy options, the most frequently utilized medication is Biktarvy, which accounts for 73 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other TX PrescribersVs. TX Avg |
|---|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 73 | $4,084.22 | ≈ Typical |
About Biktarvy: This combination product is used by itself to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product is a combination of 3 different drugs: bictegravir, emtricitabine, and tenofovir alafenamide. Bictegravir is called an integrase strand transfer inhibitor-INSTI. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, while tenofovir alafenamide is called a nucleotide reverse transcriptase inhibitor. Emtricitabine and tenofovir alafenamide are often called NRTIs. Bictegravir/emtricitabine/tenofovir alafenamide is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. In 2023, this provider wrote 73 Medicare prescriptions for Biktarvy, about 88% of the volume of the typical Texas prescriber of this medication (83). Medicare paid an average of $4,084.22 per fill, versus $3,889.52 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 73 30-Day Fills standardized to 30-day supplies 2,190 Days of Medication total across all patients in 2023 | |||
| Daptomycin | 20 | $1,140.61▼ below TX avg | ▼ Less than typical |
About Daptomycin: This medication is an antibiotic used to treat serious bacterial infections. Show more ▾ It works by stopping the growth of bacteria. This medication is not recommended for use in children younger than 12 months due to possible risk of serious side effects. A cyclic lipopeptide antibiotic that inhibits GRAM-POSITIVE BACTERIA. In 2023, this provider wrote 20 Medicare prescriptions for Daptomycin, about half the volume of the typical Texas prescriber of this medication (44). Medicare paid an average of $1,140.61 per fill, versus $1,374.92 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the TX average for this medication. 20 30-Day Fills standardized to 30-day supplies 137 Days of Medication total across all patients in 2023 | |||
| ErtapenemErtapenem Sodium | 15 | $696.74 | ▼ Less than typical |
About Ertapenem: Ertapenem is used to prevent and treat a wide variety of bacterial infections. Show more ▾ This medication is known as a carbapenem-type antibiotic. It works by stopping the growth of bacteria. A carbapenem derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of Gram-positive and Gram-negative bacterial infections including intra-abdominal infections, acute gynecological infections, complicated urinary tract infections, skin infections, and respiratory tract infections. It is also used to prevent infection in colorectal surgery. In 2023, this provider wrote 15 Medicare prescriptions for Ertapenem, about half the volume of the typical Texas prescriber of this medication (32). Medicare paid an average of $696.74 per fill, versus $621.90 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15 30-Day Fills standardized to 30-day supplies 102 Days of Medication total across all patients in 2023 | |||
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $4.69▼ below TX avg | ▼ Less than typical |
About Sulfamethoxazole-Trimethoprim: This medication is a combination of two antibiotics: sulfamethoxazole and trimethoprim. Show more ▾ It is used to treat a wide variety of bacterial infections (such as middle ear, urine, respiratory, and intestinal infections). It is also used to prevent and treat a certain type of pneumonia (pneumocystis-type). This medication should not be used by children less than 2 months of age due to the risk of serious side effects. This medication treats only certain types of infections. It will not work for viral infections (such as flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS. In 2023, this provider wrote 13 Medicare prescriptions for Sulfamethoxazole-Trimethoprim, about half the volume of the typical Texas prescriber of this medication (27). Medicare paid an average of $4.69 per fill, versus $6.17 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the TX average for this medication. 16.8 30-Day Fills standardized to 30-day supplies 488 Days of Medication total across all patients in 2023 | |||
| Valganciclovir Hcl | 13 | $165.22▼ below TX avg | ▼ Less than typical |
About Valganciclovir Hcl: Valganciclovir is an anti-viral drug. Show more ▾ It is changed in the body to the active form of the drug called ganciclovir. It is used to prevent disease caused by a virus called cytomegalovirus (CMV) in people who have received organ transplants. CMV disease can lead to serious infections in the body, including an infection in the eye, called CMV retinitis, that can cause blindness. Valganciclovir works by slowing the growth of the CMV virus. It helps prevent the spread of infection to other areas of the body. Valganciclovir is also used to treat CMV retinitis in people with advanced HIV disease (AIDS). This medication helps control CMV retinitis and decrease the risk of blindness. Valganciclovir is not a cure for CMV disease. Some people may have worsening CMV retinitis even with treatment. It is important to have your eyes checked regularly by your doctor. In 2023, this provider wrote 13 Medicare prescriptions for Valganciclovir Hcl, about a third of the volume of the typical Texas prescriber of this medication (43). Medicare paid an average of $165.22 per fill, versus $404.26 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the TX average for this medication. 13.9 30-Day Fills standardized to 30-day supplies 399 Days of Medication total across all patients in 2023 | |||
| Voriconazole | 13 | $275.79▼ below TX avg | ▼ Less than typical |
About Voriconazole: Voriconazole is used to treat a variety of fungal infections. Show more ▾ It belongs to a class of drugs known as azole antifungals. It works by stopping the growth of fungi. A triazole antifungal agent that specifically inhibits STEROL 14-ALPHA-DEMETHYLASE and CYTOCHROME P-450 CYP3A. In 2023, this provider wrote 13 Medicare prescriptions for Voriconazole, about 68% of the volume of the typical Texas prescriber of this medication (19). Medicare paid an average of $275.79 per fill, versus $651.43 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the TX average for this medication. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2023 | |||
| Minocycline Hcl | 11 | $108.65 | ▼ Less than typical |
About Minocycline Hcl: This medication is used to treat acne or rosacea. Show more ▾ Minocycline belongs to a class of drugs known as tetracycline antibiotics. However, it is not used to treat skin infections. It helps decrease pimples and red bumps that happen with acne or rosacea. A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections. In 2023, this provider wrote 11 Medicare prescriptions for Minocycline Hcl, about a third of the volume of the typical Texas prescriber of this medication (33). Medicare paid an average of $108.65 per fill, versus $32.38 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 19 30-Day Fills standardized to 30-day supplies 570 Days of Medication total across all patients in 2023 | |||
| TivicayDolutegravir Sodium | 11 | $2,235.01▼ below TX avg | ▼ Less than typical |
About Tivicay: Dolutegravir is used with other HIV medications to help control HIV infection. Show more ▾ It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Dolutegravir belongs to a class of drugs known as integrase inhibitors. It blocks the virus from growing and infecting more cells. Dolutegravir is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details. In 2023, this provider wrote 11 Medicare prescriptions for Tivicay, about a quarter of the volume of the typical Texas prescriber of this medication (49). Medicare paid an average of $2,235.01 per fill, versus $2,350.01 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average TX prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the TX average for this medication. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for MASAYUKI NIGO M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Infectious Disease prescribing approach at this Houston, TX practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among TX prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
